Nilogen Oncosystems Announces Partnership with Scailyte AG to Provide Clinically Relevant Translational Platform Supporting Development of Immuno-Oncology Therapeutics in Oncology Clinical Trials and Ultimately to Support Personalized Medicine for Patients
TAMPA, Fla. and BASEL, Switzerland, July 12, 2022 /PRNewswire/ — Nilogen Oncosystems, a leading Oncology drug development Company;…